These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 223528)

  • 1. Assessment of ACTH-adrenal activity after treatment with a glucocorticoid and an antiandrogenic steroid.
    Girard J; Baumann JB; Graf S; van Hees G; Rosenthal M; Zuppinger K
    Arch Toxicol Suppl; 1979; (2):85-92. PubMed ID: 223528
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery of hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with betamethasone.
    Hodges JR; Mitchley S
    Br J Pharmacol; 1970 Dec; 40(4):732-9. PubMed ID: 4322042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyproteroneacetate and ACTH adrenal function.
    Girard J; Baumann JB; Bühler U; Zuppinger K; Haas HG; Staub JJ; Wyss HI
    J Clin Endocrinol Metab; 1978 Sep; 47(3):581-6. PubMed ID: 233676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the pituitary corticotropin reserve with metyrapone in subjects treated with a steroid association and with the single components].
    Balestreri R; Jacopino GE; Barreca T; Cicchetti V
    Folia Endocrinol; 1974 Apr; 27(2):168-78. PubMed ID: 4363952
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of cyproterone acetate on the secretion ACTH, cortisol and testosterone, and on the urinary elimination of 17-OHCS and 17-CS in hirsute females].
    Djurić DS; Manojlović D
    Endocrinologie; 1981; 19(1):59-63. PubMed ID: 6270779
    [No Abstract]   [Full Text] [Related]  

  • 6. The impaired response to metyrapone in patients taking oestrogen.
    Sprunt JG; Rutherford ER; Nelson DH
    Acta Endocrinol (Copenh); 1968 Nov; 59(3):447-53. PubMed ID: 4301815
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal betamethasone exposure results in pituitary-adrenal hyporesponsiveness in adult sheep.
    Sloboda DM; Moss TJ; Li S; Doherty D; Nitsos I; Challis JR; Newnham JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E61-70. PubMed ID: 16882931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings: Relationship between ACTH variations during the menstrual cycle and the adrenal androgen variations.
    Genazzani AR
    Horm Res; 1975; 6(5-6):299-300. PubMed ID: 181313
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired pregnenolone secretion after combined cyproterone acetate and ethynyl estradiol therapy in hirsute patients.
    Inaudi P; D'Ambrogio G; Massafra C; Facchini V; Genazzani AR
    Gynecol Obstet Invest; 1982; 14(2):106-20. PubMed ID: 6288518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intrahypothalamic betamethazone implants on adrenal function in male sceloporus cyanogenys.
    Callard IP; Willard E
    Gen Comp Endocrinol; 1969 Dec; 13(3):460-7. PubMed ID: 4326328
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of cyproterone acetate (CPA) on gonadal and adrenal function in men.
    de la Torre B; Norén S; Hedman M; Diczfalusy E
    Contraception; 1979 Oct; 20(4):377-96. PubMed ID: 228907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cyproterone acetate-ethinyl oestradiol treatment on adrenal function in hirsute women.
    Chapman MG; Jeffcoate SL; Dewhurst CJ
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):577-82. PubMed ID: 6299625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal steroidogenic actions of cyclic nucleotide derivatives in the rat.
    Free CA; Paik VS
    Endocrinology; 1977 May; 100(5):1287-93. PubMed ID: 191239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyproterone acetate and its metabolites on the adrenal function in man, rhesus monkey and rat.
    Bhargava AS; Kapp JF; Poggel HA; Heinick J; Nieuweboer B; Günzel P
    Arzneimittelforschung; 1981; 31(6):1005-9. PubMed ID: 6266428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain monoamines and stimulation or inhibition of ACTH release.
    De Schaepdryver AF; Preziosi P; Scapagnini U
    Arch Int Pharmacodyn Ther; 1969 Jul; 180(1):11-8. PubMed ID: 4311432
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of cyproterone acetate on pituitary-adrenocortical function in man.
    van Wayjen RG; van den Ende A
    Acta Endocrinol (Copenh); 1981 Jan; 96(1):112-22. PubMed ID: 6257015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function.
    Sloboda DM; Moss TJ; Gurrin LC; Newnham JP; Challis JR
    J Endocrinol; 2002 Jan; 172(1):71-81. PubMed ID: 11786375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the site of action of the anti-adrenal steroidogenic effect of cyproterone acetate.
    Lambert A; Mitchell RM; Robertson WR
    Biochem Pharmacol; 1985 Jun; 34(12):2091-5. PubMed ID: 2988566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for adrenocortical uptake of ACTH in vivo.
    Espiner EA; Donald RA; Hart DS; Ross J; Jordan RB
    Am J Physiol; 1974 Jan; 226(1):96-104. PubMed ID: 4358854
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of adrenocorticotrophic activity in the ascorbic acid deficient guinea-pig.
    Hodges JR; Hotston RT
    Br J Pharmacol; 1971 Aug; 42(4):595-602. PubMed ID: 4329984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.